It makes sense then that Smith+Nephew, a specialist in advanced wound care and sports medicine, has said it will sponsor tennis players participating in this year’s Wimbledon championships ...

Smith+Nephew (NYSE: SNN) reported first-quarter results that fell in line with sales expectations on Wall Street.

Smith & Nephew plc engages in the ... and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

UK medical products maker Smith+Nephew beat first-quarter revenue growth expectations and maintained its full-year sales and profit margin forecasts on Wednesday, despite the potential impact of U.S.

Smith & Nephew should prepare for a long and ... a 5% stake in the $11 billion UK-listed maker of hip joints and wound care kit. Its medicine is likely to involve stripping out costs.

senior VP & GM for orthopaedics international at Smith + Nephew, said: “In 2023, we launched more than 20 new products in orthopaedics, sports medicine, and wound care. The evolution of new ...

Under the Agreement, Smith+Nephew will market and sell CENTRIO Platelet-Rich Plasma System, their own branded version of Nuo’s underlying Aurix ® System to the United States wound care market.

Unique programme aims to improve patient care through comprehensive training Dubai, UAE/Doha, Qatar: Smith & Nephew's Wound Care Academy (WCA) returns to the Middle East, with a 5-day event for wound ...

" This exclusive private label distribution agreement with Smith+Nephew is a significant development for Nuo ,” commented ...